Semaglutide.
"I’m the original. The first to quiet the food noise."
A GLP-1 receptor agonist — the molecule that started the GLP-1 conversation. It reduces appetite and helps many people lose weight alongside lifestyle changes; results vary from person to person. The most studied and most accessible of the GLP-1 family.
The compounded Semaglutide prescribed through New Tides is prepared by a state-licensed compounding pharmacy for patients with a valid prescription and is not FDA-approved. Individual results vary.
Individual results vary and are not guaranteed.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
How I work
The mechanism, in plain English.
I activate GLP-1 receptors in the pancreas, gut, and brain. I boost insulin response after meals, slow how fast food leaves your stomach, and signal fullness to the brain — quieting the food noise that drives overeating.
What you may feel
How patients describe it.
Many patients notice the food chatter dimming within the first week or two. Appetite often resets in the first month. Your results and timeline depend on your starting weight, dose titration, and metabolic context. Often the right starting place before stepping up to a dual or triple agonist.
Individual response varies. Outcomes are not guaranteed.
Want to know if Semaglutide is right for you?
Take the intake. A specialist physician reviews your answers, meets you on video, and builds a plan that fits you — not a template.
Start your intake →Educational only. Not a prescription.